Skip to main navigation Skip to search Skip to main content

Bendamustine and subcutaneous alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients

  • Marco Montillo
  • , Alessandra Tedeschi
  • , Gianluca Gaidano
  • , Marta Coscia
  • , Valeria Belsito Petrizzi
  • , Ester Orlandi
  • , Nicola Cascavilla
  • , Paolo Ghia
  • , Marina Motta
  • , Andrea Gallamini
  • , Anna Maria Frustaci
  • , Davide Rossi
  • , Lorenzo De Paoli
  • , Michele Nichelatti
  • , Enrica Morra
  • , Massimo Massaia

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)e159-e161
JournalHaematologica
Volume99
Issue number9
DOIs
Publication statusPublished - 1 Sept 2014

Keywords

  • Bendamustine
  • Effective treatment
  • Relapsed/refractory chronic lymphocytic leukemia

Cite this